2023
Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs
Baker H, Fine R, Suter F, Allore H, Hsiao B, Chowdhary V, Lavelle E, Chen P, Hintz R, Suter L, Danve A. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs. Arthritis Care & Research 2023 PMID: 37382043, DOI: 10.1002/acr.25181.Peer-Reviewed Original ResearchBest practice advisoryHepatitis B virusAutoimmune rheumatic diseasesBPA implementationSynthetic disease-modifying antirheumatic drugsDisease-modifying antirheumatic drugsHepatitis C virus infectionHepatitis B surface antigenC virus infectionUse of biologicsB surface antigenQuality improvement initiativesElectronic health recordsEligible patientsAntirheumatic drugsRheumatic diseasesRheumatology practiceSociety guidelinesB virusPractice advisoryComputerized decision support systemVirus infectionRoutine screeningPatient screeningPatients
2018
Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout
FitzGerald JD, Mikuls TR, Neogi T, Singh JA, Robbins M, Khanna PP, Turner AS, Myslinski R, Suter LG. Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout. Arthritis Care & Research 2018, 70: 659-671. PMID: 29649348, DOI: 10.1002/acr.23500.Peer-Reviewed Original ResearchConceptsRheumatology Informatics SystemElectronic clinical quality measuresClinical quality measuresElectronic health recordsAmerican CollegeProportion of patientsManagement of goutQuality of careTreatment of goutNational Quality ForumQuality Reporting ProgramGout guidelinesGout careHealth care stakeholdersHealth registriesEffectiveness (RISE) registrySerum urateClinical sitesQuality ForumNational endorsementCare stakeholdersGoutHealth recordsProcess measuresCare